Similar articles for PMID: 16969363

Year	Number of Results
1989	1
2002	1
2003	1
2004	3
2005	2
2006	7
2007	7
2008	12
2009	10
2010	6
2011	5
2012	5
2013	1
2014	4
2024	0

1

Use of pairwise marker combination and recursive partitioning in a pharmacogenetic genome-wide scan.

Warren LL, Hughes AR, Lai EH, Zaykin DV, Haneline SA, Bansal AT, Wooster AW, Spreen WR, Hernandez JE, Scott TR, Roses AD, Mosteller M; CNA30027 and CNA30032 study teams. Warren LL, et al. Pharmacogenomics J. 2007 Jun;7(3):180-9. doi: 10.1038/sj.tpj.6500414. Epub 2006 Sep 12. Pharmacogenomics J. 2007. PMID: 16969363

2

Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.

Guo Y, Shi L, Hong H, Su Z, Fuscoe J, Ning B. Guo Y, et al. Sci China Life Sci. 2013 Feb;56(2):119-24. doi: 10.1007/s11427-013-4438-8. Epub 2013 Feb 8. Sci China Life Sci. 2013. PMID: 23393027 Free article. Review.

3

The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety.

Roses AD. Roses AD. Neuropsychopharmacology. 2009 Jan;34(1):6-17. doi: 10.1038/npp.2008.153. Epub 2008 Oct 15. Neuropsychopharmacology. 2009. PMID: 18923406 Review.

4

Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an example.

Hughes AR, Brothers CH, Mosteller M, Spreen WR, Burns DK. Hughes AR, et al. Pharmacogenomics. 2009 Feb;10(2):225-33. doi: 10.2217/14622416.10.2.225. Pharmacogenomics. 2009. PMID: 19207023 Review.

5

Abacavir hypersensitivity reaction: an update.

Hughes CA, Foisy MM, Dewhurst N, Higgins N, Robinson L, Kelly DV, Lechelt KE. Hughes CA, et al. Ann Pharmacother. 2008 Mar;42(3):387-96. doi: 10.1345/aph.1K522. Epub 2008 Feb 26. Ann Pharmacother. 2008. PMID: 18303141 Review.

6

HLA-B*5701 screening for hypersensitivity to abacavir.

Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A; PREDICT-1 Study Team. Mallal S, et al. N Engl J Med. 2008 Feb 7;358(6):568-79. doi: 10.1056/NEJMoa0706135. N Engl J Med. 2008. PMID: 18256392 Free article. Clinical Trial.

7

Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility.

Hughes AR, Spreen WR, Mosteller M, Warren LL, Lai EH, Brothers CH, Cox C, Nelsen AJ, Hughes S, Thorborn DE, Stancil B, Hetherington SV, Burns DK, Roses AD. Hughes AR, et al. Pharmacogenomics J. 2008 Dec;8(6):365-74. doi: 10.1038/tpj.2008.3. Epub 2008 Mar 11. Pharmacogenomics J. 2008. PMID: 18332899 Review.

8

Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.

Berka N, Gill JM, Liacini A, O'Bryan T, Khan FM. Berka N, et al. Hum Immunol. 2012 Feb;73(2):164-7. doi: 10.1016/j.humimm.2011.12.002. Epub 2011 Dec 8. Hum Immunol. 2012. PMID: 22197535

9

Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients.

Giorgini S, Martinelli C, Tognetti L, Carocci A, Giuntini R, Mastronardi V, Torricelli F, Leoncini F, Lotti T. Giorgini S, et al. Dermatol Ther. 2011 Nov-Dec;24(6):591-4. doi: 10.1111/j.1529-8019.2012.01409.x. Dermatol Ther. 2011. PMID: 22515676

10

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.

Hetherington S, Hughes AR, Mosteller M, Shortino D, Baker KL, Spreen W, Lai E, Davies K, Handley A, Dow DJ, Fling ME, Stocum M, Bowman C, Thurmond LM, Roses AD. Hetherington S, et al. Lancet. 2002 Mar 30;359(9312):1121-2. doi: 10.1016/S0140-6736(02)08158-8. Lancet. 2002. PMID: 11943262

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

57 results

Results by year